Agilent Buys Proscia: The $270 Million Bet That Pathology's Paper Era May Be Ending

Observability can claim a growing share of IT budgets. Learn how Proscia, a pathology AI company, built a self-hosted observability platform on Amazon S3, Amazon EKS, and ClickHouse managed by the Altinity Kubernetes Operator, achieving unlimited telemetry retention at object-storage cost under HIPAA, GDPR, and data-residency requirements.

Proscia built a self-hosted observability solution using Amazon S3, ClickHouse, and the Altinity Kubernetes Operator to achieve unlimited data retention at 100x lower cost while processing 14x more telemetry data.

Healthcare-analysis giant Agilent Technologies is buying Philly-based Proscia to speed its AI-based pathology records search and analysis.

Agilent to Acquire Digital Pathology Firm Proscia for up to $270M

Oct 13 (Reuters) - Agilent Technologies said on Tuesday it would acquire pathology software maker Proscia for $240 million in cash, plus up to $30 million tied to future performance

Reported Tuesday, Oct 13 - 8:06am EDT (TheFly subscription required to read more.)

Modalidad: PresencialNivel: GradoTítulo: LicenciaturaUnidad Académica: Escuela Universitaria de Artes Contacto: Correo electrónico: musica@unq.edu.ar Autoridades: Martín Proscia - Director de la Licen...

欧州の診断サービス大手Unilabsが、Proscia社のデジタル病理プラットフォーム「Concentriq」を活用し、12カ国のネットワーク全体で病理診断業務のデジタル化を進めている。

Imagene AI will integrate its advanced H&E tools and immunohistochemistry image-analysis capabilities with Proscia's Concentriq platform.

Why didn’t anyone offer aid to her immediately after?? Cuz they’re untrained pieces of shit!! Instead he fled the scene of a MURDER 🖕🏻

The clearance also includes a predetermined change control plan to lower regulatory hurdles around changes to the software's use.

News items for the week of Sept. 22, 2025

Proscia has integrated its Concentriq platform with AWS HealthImaging to provide a cloud-native foundation for pathology.

The firm said that investors provided better-than-expected backing as the company anticipates growing use of its digital pathology platform in 2025.

Read more

Aaron Weitzman / Axios: Philadelphia-based Proscia, which provides pathology digitization software, raised $50M led by Insight Partners and others, taking its total funding to $130M  —  Proscia, a pathology digitization software provider, received $50…

ABD merkezli Proscia'ın 50 milyon dolarlık yatırım turuna Insight Partners, AI Capital Partners ve Triangle Peak Partners ortaklaşa liderlik etti.

Bioptimus, a French startup, has collaborated with Proscia to accelerate AI innovation in scientific research and drug development for improved patient care. The partnership makes Bioptimus' H-optimus-0 foundation model available on Proscia's Concentriq platform, enabling researchers and data scientists to develop AI models at unprecedented speed and scale. H-optimus-0 is the largest open-source AI foundation model tailored specifically for pathology, with 1.1 billion parameters, delivering state-of-the-art performance in critical tasks such as detecting cancerous cells and identifying genetic abnormalities in tumors. David Cahané, Co-Founder and General Manager at Bioptimus, said that H-optimus-0 has set new benchmarks in AI performance and will empower the scientific community to achieve breakthroughs in precision medicine and therapeutic research. David West, CEO at Proscia, added that the integration of H-optimus-0 into Concentriq Embeddings will help users rapidly build high-performing algorithms at scale, unlocking the promise of AI-driven therapeutic research and development.